StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher Diagnostics — Core Sales Growth by Quarter

Diagnostics — Core Sales Growth (%) (%)

QuarterlyAnnual

Danaher Diagnostics — Core Sales Growth: 0.5% in Q3 2026, down 3.0 pts from a year earlier.

Latest, Q3 2026
0.5%
Period ended Sep 30, 2026
Change on a year earlier
-3.0 pts
3.5% in Q3 2025
History
20 quarters
Since Q4 2021
Sources
13
Documents cited below

Where the Q3 2026 figure comes from

Source: Danaher IR — nongaap_2026Q3 ↗

Includes Cepheid, Beckman Coulter Diagnostics, Radiometer, Leica Biosystems, HemoCue, Mammotome, and Masimo (from 10/06/2026).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiagnostics — Core Sales Growth (%) (%)Year on yearSource
Q3 2026Sep 30, 20260.5%-3.0 ptsDanaher IR — nongaap_2026Q3 ↗
Q2 2026Jun 30, 20262.0%0.0 ptsDanaher IR — nongaap_2026Q2 ↗
Q1 2026Mar 31, 2026-4.0%-2.5 ptsDanaher IR — nongaap_2026Q1 ↗
Q4 2025Dec 31, 20252.0%+4.0 ptsDanaher IR — nongaap_2025Q4 ↗
Q3 2025Sep 30, 20253.5%-1.5 ptsDanaher IR — nongaap_2025Q3 ↗
Q2 2025Jun 30, 20252.0%-1.0 ptsDanaher IR — nongaap_2025Q2 ↗
Q1 2025Mar 31, 2025-1.5%-9.0 ptsDanaher IR — nongaap_2025Q1 ↗
Q4 2024Dec 31, 2024-2.0%+6.5 ptsDanaher IR — nongaap_2024Q4 ↗
Q3 2024Sep 30, 20245.0%+20.5 ptsDanaher IR — nongaap_2024Q3 ↗
Q2 2024Jun 30, 20243.0%+14.5 ptsDanaher IR — nongaap_2024Q2 ↗
Q1 2024Mar 31, 20247.5%+15.0 ptsDanaher IR — nongaap_2024Q1 ↗
Q4 2023Dec 31, 2023-8.5%-16.0 ptsDanaher IR — nongaap_2023Q4 ↗
Q3 2023Sep 30, 2023-15.5%-29.0 ptsDanaher IR — nongaap_ex_veralto ↗
Q2 2023Jun 30, 2023-11.5%-24.0 ptsDanaher IR — nongaap_ex_veralto ↗
Q1 2023Mar 31, 2023-7.5%-30.0 ptsDanaher IR — nongaap_ex_veralto ↗
Q4 2022Dec 31, 20227.5%-23.5 ptsDanaher IR — nongaap_ex_veralto ↗

Breakdown

What makes up diagnostics — Core Sales Growth

Cite this data

StockData. (2026). Danaher Diagnostics — Core Sales Growth (%), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/core-sales-growth-diag

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.